NCT01266044

Brief Summary

The goal of this clinical research study is to learn if acupuncture can help to prevent xerostomia (dry mouth) and improve the quality of life in patients who receive radiation treatment to the head and neck. This study will determine if one acupuncture treatment approach is more effective than another. Dry mouth is a common problem among cancer patients who have received radiation treatment to the head and neck.

Trial Health

78
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
435

participants targeted

Target at P75+ for phase_3 head-and-neck-cancer

Timeline
7mo left

Started Dec 2011

Longer than P75 for phase_3 head-and-neck-cancer

Geographic Reach
2 countries

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Dec 2011Dec 2026

First Submitted

Initial submission to the registry

December 22, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 24, 2010

Completed
12 months until next milestone

Study Start

First participant enrolled

December 9, 2011

Completed
15.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

15.1 years

First QC Date

December 22, 2010

Last Update Submit

April 13, 2026

Conditions

Keywords

Radiation-induced xerostomiaAcupunctureOropharyngeal cancerRadiation TherapyIMRTDry mouth

Outcome Measures

Primary Outcomes (1)

  • Self-Reported Xerostomia Symptoms Using the Xerostomia Questionnaire (XQ)

    Xerostomia Questionnaire (XQ), an 8-item questionnaire where subjects rate each symptom on an 11-point ordinal Likert scale from 0 to 10, with higher scores indicating greater dryness or discomfort due to dryness.

    4 weeks

Study Arms (3)

Acupuncture - Group 1

EXPERIMENTAL

Acupuncture at 14 points. The needles will remain in place for 20 minutes with each treatment. Questionnaires - Baseline assessments will be completed within 7 days prior to starting radiotherapy, and patients will then complete the same assessments again at week 4 and 7 of radiotherapy and 3, 6, and 12 months after the end of radiotherapy.

Procedure: Acupuncture - Group 1Other: Standard CareOther: Questionnaire

Acupuncture - Group 2

ACTIVE COMPARATOR

Acupuncture needles placed at different points from Group 1. The needles will remain in place for 20 minutes with each treatment. Questionnaires - Baseline assessments will be completed within 7 days prior to starting radiotherapy, and patients will then complete the same assessments again at week 4 and 7 of radiotherapy and 3, 6, and 12 months after the end of radiotherapy.

Procedure: Acupuncture - Group 2Other: Standard CareOther: Questionnaire

Standard Care

OTHER

Standard oral care recommendations. Participants in all groups will receive the same recommendations. Questionnaires - Baseline assessments will be completed within 7 days prior to starting radiotherapy, and patients will then complete the same assessments again at week 4 and 7 of radiotherapy and 3, 6, and 12 months after the end of radiotherapy.

Other: Standard CareOther: Questionnaire

Interventions

Acupuncture at 14 points. The needles will remain in place for 20 minutes with each treatment.

Acupuncture - Group 1

Acupuncture needles placed at different points from Group 1. The needles will remain in place for 20 minutes with each treatment.

Acupuncture - Group 2

Standard oral care recommendations. Participants in all groups will receive the same recommendations.

Acupuncture - Group 1Acupuncture - Group 2Standard Care

Baseline assessments will be completed within 7 days prior to starting radiotherapy, and patients will then complete the same assessments again at week 4 and 7 of radiotherapy and 3, 6, and 12 months after the end of radiotherapy.

Acupuncture - Group 1Acupuncture - Group 2Standard Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age and be able to give informed consent.
  • Diagnosed with head and neck cancer, which will be primarily oropharyngeal, and scheduled to undergo IMRT with or without concurrent chemotherapy at M. D. Anderson.
  • Treatment plan that includes external beam radiation at a mean dose of at least 24 Gy or more to one of the parotid glands (the other gland can receive less than 24 Gy).
  • Anatomically intact parotid and submandibular glands.
  • Karnofsky performance status \> 60.

You may not qualify if:

  • History of xerostomia prior to head and neck radiation therapy or history of Sjögren's disease or another underlying systemic illness known to cause xerostomia.
  • Prior head and neck radiation treatment.
  • Suspected or confirmed physical closure of salivary gland ducts on either side.
  • Known bleeding disorders or taking any dose of warfarin or heparin.
  • Upper or lower extremity deformities that could interfere with accurate acupoint location or alter the energy pathway as defined by traditional acupuncture theory.
  • Local skin infections at or near the acupuncture sites or active systemic infection.
  • History of cerebrovascular accident or spinal cord injury since the mechanism of acupuncture may be associated with central nervous system activity.
  • Mental incapacitation or significant emotional or psychiatric disorder that, in the opinion of the investigator, precludes study entry as these patients may not be able to cooperate with this slightly invasive procedure or with the data collection process.
  • Current acknowledged use of any illicit drugs or evidence of alcohol abuse as defined by The American Psychiatric Association criteria.
  • Current acknowledged use of amifostine, cholinergic agonist medications (pilocarpine, cevimeline), certain beta adrenergic antagonists, anticholinergic agents, or any saliva substitute or other medication/herbal preparation known to affect salivary function (see Appendix F).
  • Patients who are currently receiving acupuncture for any condition or if they have ever had acupuncture before.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Fudan University Cancer Hospital

Shanghai, China

Location

Related Publications (2)

  • Ratcliff CG, Ahn A, Custodio AL, Garcia MK, Meng Z, Rosenthal DI, Shen Y, Chambers MS, Hu C, Cohen L. The differential effects of social support on quality of life in head and neck cancer patients in the United States and China. Eur J Oncol Nurs. 2026 Feb 20;81:103156. doi: 10.1016/j.ejon.2026.103156. Online ahead of print.

  • Garcia MK, Meng Z, Rosenthal DI, Shen Y, Chambers M, Yang P, Wei Q, Hu C, Wu C, Bei W, Prinsloo S, Chiang J, Lopez G, Cohen L. Effect of True and Sham Acupuncture on Radiation-Induced Xerostomia Among Patients With Head and Neck Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2019 Dec 2;2(12):e1916910. doi: 10.1001/jamanetworkopen.2019.16910.

Related Links

MeSH Terms

Conditions

Head and Neck NeoplasmsOropharyngeal NeoplasmsXerostomia

Interventions

Standard of CareSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsPharyngeal NeoplasmsOtorhinolaryngologic NeoplasmsPharyngeal DiseasesStomatognathic DiseasesOtorhinolaryngologic DiseasesSalivary Gland DiseasesMouth Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsPublic HealthEnvironment and Public Health

Study Officials

  • Lorenzo Cohen, PHD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2010

First Posted

December 24, 2010

Study Start

December 9, 2011

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 16, 2026

Record last verified: 2026-04

Locations